Home » Healthcare » Japan Peritoneal Dialysis Market

Japan Peritoneal Dialysis Market By Type (Continuous Ambulatory Peritoneal Dialysis [CAPD], Automated Peritoneal Dialysis [APD]); By Product (Peritoneal Dialysis Machines, Peritoneal Dialysis Solutions, Dialysis Catheters, Others); By End-User (Hospitals, Dialysis Centers, Home Care Settings) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Summary
Table Of Content

REPORT ATTRIBUTE	DETAILS
Historical Period	2019-2022
Base Year	2023
Forecast Period	2024-2032
Japan Peritoneal Dialysis Market Size 2023	USD 578.32 million
Japan Peritoneal Dialysis Market, CAGR	6.26%
Japan Peritoneal Dialysis Market Size 2032	USD 974.28 million

Market Overview

The Japan Peritoneal Dialysis Market is projected to grow from USD 578.32 million in 2023 to USD 974.28 million by 2032, with a compound annual growth rate (CAGR) of 6.26%.

The Japan Peritoneal Dialysis market is driven by the increasing prevalence of kidney diseases, the aging population, and the growing adoption of home-based dialysis treatments. As the number of patients with chronic kidney disease rises, there is a growing demand for convenient and cost-effective alternatives to in-center hemodialysis, with peritoneal dialysis offering a viable solution. Technological advancements in dialysate solutions, catheters, and automated peritoneal dialysis machines are also enhancing treatment efficiency and patient outcomes. Additionally, government initiatives and healthcare reforms in Japan are promoting greater access to peritoneal dialysis. The trend towards home healthcare and remote monitoring is further accelerating the adoption of peritoneal dialysis, providing patients with more flexible treatment options.

The geographical analysis of the Japan Peritoneal Dialysis market reveals significant regional variation in the adoption of dialysis treatments. The Kanto region, including Tokyo, leads in terms of demand due to its advanced healthcare infrastructure and high population density. The Kansai region, with cities like Osaka and Kyoto, follows closely, driven by a large elderly population and growing healthcare initiatives. Other regions, such as Chubu and Kyushu, are also seeing increased adoption, particularly with the rise in home dialysis solutions. Key players in the Japanese market include prominent companies like Nipro Corporation, Baxter International Inc., Fresenius Medical Care, and Terumo Corporation, which dominate the market with their advanced dialysis products, including automated peritoneal dialysis systems, solutions, and catheters. These companies play a vital role in expanding access to peritoneal dialysis across the country, supporting both in-center and home-based treatment options.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

Market Insights

The Japan Peritoneal Dialysis market was valued at USD 578.32 million in 2023 and is expected to reach USD 974.28 million by 2032, growing at a CAGR of 6.26%.
The increasing prevalence of chronic kidney disease and the aging population are key drivers for the market’s growth.
Growing preference for home dialysis treatments, especially Automated Peritoneal Dialysis (APD), is driving demand.
Technological advancements in peritoneal dialysis machines and solutions are improving patient outcomes and convenience.
Major players in the market include Nipro Corporation, Baxter International, and Fresenius Medical Care, leading the market with innovative products.
High treatment costs and the risk of infections in home dialysis remain significant market restraints.
Regional adoption varies, with the Kanto and Kansai regions leading in market share, while other regions like Chubu and Kyushu show gradual growth.

Market Drivers

Rising Prevalence of Kidney Diseases

The increasing prevalence of kidney diseases in Japan is a key driver of the peritoneal dialysis market. Chronic kidney disease (CKD) is becoming more common, particularly among the aging population, which has led to a greater need for dialysis treatments. For instance, a study found that the prevalence of CKD in Japan was estimated at 13.2% of the adult population. As kidney disease progresses, patients often require renal replacement therapies such as peritoneal dialysis, making it a critical solution for managing the growing burden of CKD. With early detection and treatment, peritoneal dialysis offers patients a feasible alternative to in-center hemodialysis, thus driving market growth.

Technological Advancements

Technological innovations in peritoneal dialysis products are enhancing patient experience and improving treatment outcomes. Automated peritoneal dialysis (APD) systems, which allow patients to manage their treatment at home, have significantly improved in efficiency and ease of use. Additionally, advancements in dialysate solutions and catheter technologies are contributing to better patient care by reducing complications and improving comfort during the procedure. For instance, the Japanese government approved the use of telemedicine systems for peritoneal dialysis in 2022, which has enhanced remote monitoring and patient management. These innovations are encouraging more patients to choose peritoneal dialysis, driving market growth.

Aging Population

Japan has one of the oldest populations globally, with a significant percentage of its citizens over the age of 65. The aging population is highly susceptible to conditions such as kidney failure, which increases the demand for dialysis treatments. As elderly patients prefer the convenience and flexibility of home dialysis solutions, peritoneal dialysis presents an attractive option, driving its adoption. The shift towards home-based therapies is expected to continue as the elderly population grows, further fueling market expansion.

Government Support and Healthcare Reforms

The Japanese government has been actively supporting the adoption of peritoneal dialysis as part of its healthcare reforms. Policies aimed at improving access to dialysis treatments and reducing healthcare costs are driving the market. Japan’s healthcare system also supports home dialysis through subsidies and reimbursement programs, making peritoneal dialysis more affordable and accessible to patients. These initiatives are expected to continue to drive the market, making peritoneal dialysis an increasingly popular choice for kidney disease management.

Market Trends

Shift Towards Home-Based Dialysis

A major trend in the Japan Peritoneal Dialysis market is the increasing preference for home-based dialysis solutions. As patients seek greater autonomy and flexibility, home dialysis options, such as automated peritoneal dialysis (APD), are gaining popularity. These systems allow patients to perform their dialysis treatments in the comfort of their own homes, reducing the need for frequent hospital visits. For instance, the 2022 Annual Dialysis Data Report by the Japanese Society for Dialysis Therapy (JSDT) indicated that the number of peritoneal dialysis patients was 10,531, with a significant portion opting for home-based treatments. The convenience, coupled with improved clinical outcomes, is driving the trend toward home-based treatments, particularly among Japan’s aging population.

Growing Adoption of Automated Peritoneal Dialysis (APD)

Automated peritoneal dialysis (APD) is becoming more widely adopted in Japan due to its efficiency and ease of use. Unlike traditional manual peritoneal dialysis, APD systems can be programmed to perform dialysis treatments automatically, often while the patient sleeps. This innovation allows for more precise fluid management and better patient outcomes. The growing availability of these automated systems, along with continuous improvements in technology, is driving the trend of increased APD adoption in Japan.

Integration of Remote Monitoring and Telehealth

The integration of remote monitoring and telehealth in peritoneal dialysis is a growing trend in Japan. With the rise of digital health technologies, patients and healthcare providers can now monitor dialysis sessions remotely. This allows for real-time adjustments and enhanced patient support, especially for those receiving treatment at home. Remote monitoring reduces the need for frequent hospital visits and ensures timely interventions in case of complications. As Japan continues to embrace telemedicine, this trend is expected to further enhance the adoption and management of peritoneal dialysis.

Focus on Patient-Centered Care

The trend towards patient-centered care is shaping the Japan Peritoneal Dialysis market. Healthcare providers are increasingly focusing on personalized treatment plans to improve patient outcomes and quality of life. This includes tailored dialysis regimens based on individual needs and preferences, ensuring that patients are more actively involved in their treatment. As the demand for better patient experiences grows, innovations that offer greater comfort, ease of use, and personalization in peritoneal dialysis are expected to become more prominent, further driving market trends.

Market Challenges Analysis

Complications and Risk of Infections

Another challenge facing the growth of the peritoneal dialysis market in Japan is the risk of infections and other complications associated with the procedure. Peritoneal dialysis, particularly when performed at home, can lead to peritonitis and other infection-related issues if proper hygiene and care protocols are not followed. Despite advancements in technology and improvements in product design, complications remain a concern, and these risks may discourage patients from opting for peritoneal dialysis. For instance, the JSDT’s 2019 report highlighted that peritonitis rates among peritoneal dialysis patients were a significant concern, with infection being one of the leading causes of complications. Additionally, the need for proper training and continuous monitoring adds to the complexity of managing peritoneal dialysis effectively. Addressing these challenges is essential to improving patient outcomes and ensuring the widespread adoption of peritoneal dialysis in Japan.

High Cost of Peritoneal Dialysis Equipment

One of the primary challenges facing the Japan Peritoneal Dialysis market is the high cost of dialysis equipment and consumables. While peritoneal dialysis is often seen as a cost-effective alternative to in-center hemodialysis in the long run, the initial investment in equipment, such as automated peritoneal dialysis (APD) machines, catheters, and dialysate solutions, can be prohibitive for some patients. This upfront cost can deter patients from choosing peritoneal dialysis, especially in a country where healthcare expenses remain a significant concern. Although government subsidies and insurance coverage help offset some of these costs, the financial burden on patients still presents a barrier to wider adoption.

Market Opportunities

Expansion of Home Dialysis Programs

A significant market opportunity in Japan’s peritoneal dialysis sector lies in the expansion of home dialysis programs. As more patients prefer the convenience, flexibility, and comfort of home-based treatments, the demand for home dialysis solutions is growing. Automated peritoneal dialysis (APD) systems, which enable patients to perform dialysis at home with minimal intervention, present an attractive option for both patients and healthcare providers. The Japanese government’s focus on reducing healthcare costs by encouraging home-based treatments further supports this opportunity. With technological advancements improving the efficiency and safety of home dialysis, there is potential for widespread adoption, especially among the aging population that values independence and quality of life.

Technological Innovations and Personalized Care

Another opportunity in the Japan Peritoneal Dialysis market is the integration of technological innovations and personalized care. Advancements in dialysis machines, monitoring systems, and dialysate solutions are enhancing treatment outcomes and making peritoneal dialysis more efficient and patient-friendly. Additionally, the shift toward personalized medicine, where dialysis regimens are tailored to individual patient needs, opens avenues for improved care and patient satisfaction. The increasing use of remote monitoring and telehealth technologies provides patients with real-time support, making it easier to manage their treatment at home. These innovations create a favorable environment for market growth, offering new solutions that address patient-specific needs while enhancing overall efficiency in the peritoneal dialysis process.

Market Segmentation Analysis:

By Type:

The Japan Peritoneal Dialysis market is segmented by type into Continuous Ambulatory Peritoneal Dialysis (CAPD) and Automated Peritoneal Dialysis (APD). CAPD remains a widely used method, especially for patients who prefer a manual, non-automated approach. This type of dialysis requires patients to perform exchanges several times a day, providing greater flexibility but also requiring significant patient involvement. On the other hand, APD is gaining traction due to its convenience and efficiency. APD systems automate the dialysis process, allowing patients to undergo treatment while sleeping, which improves patient compliance and comfort. As technological advancements make APD systems more user-friendly and affordable, its adoption is expected to increase, particularly among Japan’s aging population, who seek home dialysis options for better autonomy and quality of life.

By Product:
The product segment of the Japan Peritoneal Dialysis market includes peritoneal dialysis machines, dialysis solutions, dialysis catheters, and other accessories. Peritoneal dialysis machines, particularly automated systems, are experiencing higher demand due to their ability to facilitate home-based dialysis, which is a growing trend in Japan. Dialysis solutions, essential for the dialysis process, are also in demand as they support effective treatment and enhance patient outcomes. Dialysis catheters, which provide access to the peritoneum, are a critical component of the procedure, with innovations focusing on improving safety and reducing infection risks. The “other” category includes products like connectors and filters that contribute to the overall dialysis process. As the market grows, technological improvements in these products, along with increasing adoption of home dialysis, will continue to shape this segment.

Segments:

Based on Type:

Continuous Ambulatory Peritoneal Dialysis (CAPD)
Automated Peritoneal Dialysis (APD)

Based on Product:

Peritoneal Dialysis Machines
Peritoneal Dialysis Solutions
Dialysis Catheters
Others

Based on End-user:

Hospitals
Dialysis Centers
Home Care Settings

Based on the Geography:

Kanto Region
Kansai Region
Chubu Region
Kyushu Region
Other Regions

Regional Analysis

Kanto Region

The Kanto region, including Tokyo and its surrounding areas, holds the largest market share in the Japan Peritoneal Dialysis market, accounting for approximately 40-45% of the total market. This region benefits from its high population density, advanced healthcare infrastructure, and proximity to leading medical research centers. Tokyo, as the capital city, is home to numerous top-tier hospitals and dialysis centers, which contribute to the high adoption rate of peritoneal dialysis. With an aging population and increasing awareness of home dialysis solutions, the Kanto region is expected to maintain its dominant position in the market, supported by technological advancements and government healthcare policies aimed at improving access to dialysis treatments.

Kansai Region

The Kansai region, which includes Osaka, Kyoto, and Kobe, holds a significant share of the Japan Peritoneal Dialysis market, representing around 25-30% of the total market. The region’s large elderly population and well-established healthcare infrastructure make it a key player in the adoption of peritoneal dialysis. With growing awareness about the benefits of home dialysis, particularly automated peritoneal dialysis (APD), the Kansai region is seeing increased demand for peritoneal dialysis treatments. The regional healthcare system is expanding access to these services, positioning Kansai as one of the leading areas for market growth in Japan.

Chubu Region

The Chubu region, encompassing cities like Nagoya, holds approximately 15-20% of the Japan Peritoneal Dialysis market. Although the market share is smaller compared to Kanto and Kansai, the region is seeing steady growth in the demand for peritoneal dialysis due to its aging population and rising incidence of kidney diseases. Chubu is home to a number of healthcare facilities that are increasingly adopting home dialysis solutions to meet patient needs. As the region continues to focus on improving healthcare access and patient care, the market share of peritoneal dialysis is expected to expand in the coming years.

Kyushu Region

The Kyushu region, which includes cities like Fukuoka, holds a smaller market share of approximately 10-12%, but it is experiencing growth due to its aging population and the increasing adoption of home dialysis. In addition, the “Other Regions” category, which covers rural and less densely populated areas, contributes around 5-8% of the market. While these regions have lower market shares, the growing need for accessible and cost-effective dialysis treatments, supported by government reforms and healthcare initiatives, is expected to drive steady growth in peritoneal dialysis adoption. These regions are witnessing gradual market expansion as healthcare providers enhance access to dialysis services in rural areas.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Key Player Analysis

Nipro Corporation
Baxter International Inc.
Fresenius Medical Care
Terumo Corporation
Asahi Kasei Medical Co., Ltd.
Huaren Pharmaceutical Co., Ltd.
JMS Co., Ltd.
Kawasumi Laboratories Inc.
Medtronic plc
Pacific Hospital Supply Co., Ltd.

Competitive Analysis

The Japan Peritoneal Dialysis market is highly competitive, with several key players dominating the landscape. Leading companies include Nipro Corporation, Baxter International Inc., Fresenius Medical Care, Terumo Corporation, Asahi Kasei Medical Co., Ltd., Huaren Pharmaceutical Co., Ltd., JMS Co., Ltd., Kawasumi Laboratories Inc., Medtronic plc, and Pacific Hospital Supply Co., Ltd. Key players are focused on product innovation, particularly in the development of automated systems and peritoneal dialysis solutions that improve patient comfort and treatment efficiency. The competition is driven by technological advancements, such as the integration of remote monitoring capabilities and improvements in dialysis machines to enhance usability and reduce the risk of complications. In addition, companies are increasingly focusing on expanding their product portfolios to address specific patient needs, particularly in the growing home dialysis segment. This is in response to the increasing preference for home-based dialysis, driven by patient convenience and the need for greater independence. For instance, the JSDT’s 2022 report highlighted that 20.3% of peritoneal dialysis patients received hybrid therapy, combining peritoneal dialysis with hemodialysis or hemodiafiltration to better meet individual patient needs. Companies are also making efforts to enhance distribution networks, ensuring wider access to peritoneal dialysis treatments in both urban and rural regions. However, challenges remain, such as the high cost of treatment and the risk of infections, which impact patient outcomes and healthcare costs. Companies are continuously working on overcoming these barriers by focusing on the development of safer, cost-effective solutions. This competitive environment fosters innovation and encourages companies to improve the quality and accessibility of peritoneal dialysis in Japan.

Recent Developments

In August 2024, Baxter International Inc (US) and Carlyle (US) signed a definitive agreement under which Carlyle will acquire Baxter’s Kidney Care segment. The segment will be named Vantive, with the aim of creating a standalone kidney care company.

In April 2023, Medtronic plc (Ireland) and DaVita Inc (US) launched Mozarc Medical—an independent new company that aims to reshape kidney health and drive patient-centered technology solutions.

In August 2022, Fresenius Medical Care AG (Germany) acquired InterWell Health (US), a physician organization that drives innovation in the kidney care space in the US, and Cricket Health. Inc (US), provider of value-based kidney care with patient engagement and data platform.

Market Concentration & Characteristics

The Japan Peritoneal Dialysis market exhibits moderate concentration, with a few large players dominating the landscape, while a number of smaller, specialized companies contribute to niche segments. Major global healthcare companies have established strong presences in Japan, leveraging their advanced technological capabilities and extensive distribution networks. These companies offer a broad range of peritoneal dialysis solutions, including automated systems, dialysis solutions, and catheters, driving the market’s growth. The market characteristics are shaped by the increasing demand for home dialysis solutions, particularly Automated Peritoneal Dialysis (APD), which is gaining preference due to its convenience and efficiency. The market is characterized by continuous innovation, with companies focusing on improving the safety, usability, and affordability of dialysis treatments. The rising aging population and the prevalence of chronic kidney disease are key factors contributing to market expansion. At the same time, competition is fueled by the need for cost-effective solutions, as healthcare providers and patients seek affordable yet reliable treatment options. The regulatory environment in Japan also plays a critical role in shaping market dynamics, ensuring the safety and efficacy of dialysis products. As the demand for home dialysis increases, companies are responding by enhancing their product offerings and expanding their reach, fostering a dynamic and competitive market environment.

Report Coverage

The research report offers an in-depth analysis based on Type, Product, End-User and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

The Japan Peritoneal Dialysis market is expected to experience steady growth driven by an aging population and increasing prevalence of chronic kidney disease.
Automated Peritoneal Dialysis (APD) systems will continue to see increased adoption due to their convenience and improved patient outcomes.
Technological advancements, such as remote monitoring and smart dialysis solutions, are anticipated to transform the treatment landscape.
Home dialysis options are expected to gain more market share as patients prefer treatment flexibility and reduced need for frequent hospital visits.
Companies are likely to focus on developing cost-effective solutions to make peritoneal dialysis more accessible to a wider patient base.
Regulatory approvals and healthcare reforms will continue to impact product availability and market dynamics.
There will be increased emphasis on infection control and safety measures in peritoneal dialysis products.
Partnerships and collaborations among healthcare providers and technology companies are expected to drive market growth.
Long-term care facilities will play a crucial role in supporting the adoption of peritoneal dialysis treatments.
Rising investments in research and development will continue to push innovation in peritoneal dialysis technologies.

CHAPTER NO. 1 : INTRODUCTION 20

1.1.1. Report Description 20

Purpose of the Report 20

USP & Key Offerings 20

1.1.2. Key Benefits for Stakeholders 20

1.1.3. Target Audience 21

1.1.4. Report Scope 21

CHAPTER NO. 2 : EXECUTIVE SUMMARY 22

2.1. Peritoneal Dialysis Market Snapshot 22

2.1.1. Japan Peritoneal Dialysis Market, 2018 – 2032 (USD Million) 23

CHAPTER NO. 3 : GEOPOLITICAL CRISIS IMPACT ANALYSIS 24

3.1. Russia-Ukraine and Israel-Palestine War Impacts 24

CHAPTER NO. 4 : PERITONEAL DIALYSIS MARKET – INDUSTRY ANALYSIS 25

4.1. Introduction 25

4.2. Market Drivers 26

4.2.1. Rising prevalence of chronic kidney diseases (CKD) 26

4.2.2. Growing adoption of home dialysis treatments 27

4.3. Market Restraints 28

4.3.1. High cost of peritoneal dialysis equipment and treatments 28

4.4. Market Opportunities 29

4.4.1. Technological advancements in automated dialysis systems 29

4.5. Porter’s Five Forces Analysis 30

4.6. Buying Criteria 31

CHAPTER NO. 5 : IMPORT EXPORT ANALYSIS 32

5.1. Import Analysis by Japan 32

5.1.1. Japan Peritoneal Dialysis Market Import Volume/Revenue, By Japan, 2018 – 2023 32

5.2. Export Analysis by Japan 33

5.2.1. Japan Peritoneal Dialysis Market Export Volume/Revenue, By Japan, 2018 – 2023 33

CHAPTER NO. 6 : DEMAND SUPPLY ANALYSIS 34

6.1. Demand Analysis by Japan 34

6.1.1. Japan Peritoneal Dialysis Market Demand Volume/Revenue, By Japan, 2018 – 2023 34

6.2. Supply Analysis by Japan 35

6.2.1. Japan Peritoneal Dialysis Market Supply Volume/Revenue, By Japan, 2018 – 2023 35

CHAPTER NO. 7 : PRODUCTION ANALYSIS 36

7.1. Production Analysis by Japan 36

7.1.1. Japan Peritoneal Dialysis Market Production Volume/Revenue, By Japan, 2018 – 2023 36

CHAPTER NO. 8 : PRICE ANALYSIS 37

8.1. Price Analysis by Type 37

8.1.1. Japan Peritoneal Dialysis Market Price, By Type, 2018 – 2023 37

8.1.2. Japan Type Market Price, By Type, 2018 – 2023 37

CHAPTER NO. 9 : RAW MATERIALS ANALYSIS 38

9.1. Key Raw Materials and Suppliers 38

9.2. Key Raw Materials Price Trend 38

CHAPTER NO. 10 : MANUFACTURING COST ANALYSIS 39

10.1. Manufacturing Cost Analysis 39

10.2. Manufacturing Process 39

CHAPTER NO. 11 : ANALYSIS COMPETITIVE LANDSCAPE 40

11.1. Company Market Share Analysis – 2023 40

11.2. Value Chain Analysis 40

11.2.1. Japan Peritoneal Dialysis Market: Company Market Share, by Volume, 2023 41

11.2.2. Japan Peritoneal Dialysis Market: Company Market Share, by Revenue, 2023 42

11.2.3. Japan Peritoneal Dialysis Market: Top 6 Company Market Share, by Revenue, 2023 42

11.2.4. Japan Peritoneal Dialysis Market: Top 3 Company Market Share, by Revenue, 2023 43

11.3. Japan Peritoneal Dialysis Market Company Volume Market Share, 2023 44

11.4. Japan Peritoneal Dialysis Market Company Revenue Market Share, 2023 45

11.5. Company Assessment Metrics, 2023 45

11.5.1. Stars 45

11.5.2. Emerging Leaders 45

11.5.3. Pervasive Players 45

11.5.4. Participants 45

11.6. Start-ups /SMEs Assessment Metrics, 2023 45

11.6.1. Progressive Companies 45

11.6.2. Responsive Companies 46

11.6.3. Dynamic Companies 46

11.6.4. Starting Blocks 46

11.7. Strategic Developments 47

11.7.1. Acquisitions & Mergers 47

New Product Launch 47

Japan Expansion 47

11.8. Key Players Product Matrix 48

CHAPTER NO. 12 : PESTEL & ADJACENT MARKET ANALYSIS 49

12.1. PESTEL 49

12.1.1. Political Factors 49

12.1.2. Economic Factors 49

12.1.3. Social Factors 49

12.1.4. Technological Factors 49

12.1.5. Environmental Factors 49

12.1.6. Legal Factors 49

12.2. Adjacent Market Analysis 49

CHAPTER NO. 13 : PERITONEAL DIALYSIS MARKET – BY TYPE SEGMENT ANALYSIS 50

13.1. Peritoneal Dialysis Market Overview, by Type Segment 50

13.1.1. Peritoneal Dialysis Market Revenue Share, By Type, 2023 & 2032 51

13.1.2. Peritoneal Dialysis Market Attractiveness Analysis, By Type 52

13.1.3. Incremental Revenue Growth Opportunity, by Type, 2024 – 2032 52

13.1.4. Peritoneal Dialysis Market Revenue, By Type, 2018, 2023, 2027 & 2032 53

13.2. Continuous Ambulatory Peritoneal Dialysis (CAPD) 54

13.3. Automated Peritoneal Dialysis (APD) 55

CHAPTER NO. 14 : PERITONEAL DIALYSIS MARKET – BY PRODUCT SEGMENT ANALYSIS 56

14.1. Peritoneal Dialysis Market Overview, by Product Segment 56

14.1.1. Peritoneal Dialysis Market Revenue Share, By Product, 2023 & 2032 57

14.1.2. Peritoneal Dialysis Market Attractiveness Analysis, By Product 58

14.1.3. Incremental Revenue Growth Opportunity, by Product, 2024 – 2032 58

14.1.4. Peritoneal Dialysis Market Revenue, By Product, 2018, 2023, 2027 & 2032 59

14.2. Peritoneal Dialysis Machines 60

14.3. Peritoneal Dialysis Solutions 61

14.4. Dialysis Catheters 62

14.5. Others 63

CHAPTER NO. 15 : PERITONEAL DIALYSIS MARKET – BY END-USER SEGMENT ANALYSIS 64

15.1. Peritoneal Dialysis Market Overview, by End-user Segment 64

15.1.1. Peritoneal Dialysis Market Revenue Share, By End-user, 2023 & 2032 65

15.1.2. Peritoneal Dialysis Market Attractiveness Analysis, By End-user 66

15.1.3. Incremental Revenue Growth Opportunity, by End-user, 2024 – 2032 66

15.1.4. Peritoneal Dialysis Market Revenue, By End-user, 2018, 2023, 2027 & 2032 67

15.2. Hospitals 68

15.3. Dialysis Centers 69

15.4. Home Care Settings 70

CHAPTER NO. 16 : PERITONEAL DIALYSIS MARKET – JAPAN ANALYSIS 71

16.1. Type 71

16.1.1. Japan Peritoneal Dialysis Market Revenue, By Type, 2018 – 2023 (USD Million) 71

16.2. Japan Peritoneal Dialysis Market Revenue, By Type, 2024 – 2032 (USD Million) 71

16.3. Product 72

16.3.1. Japan Peritoneal Dialysis Market Revenue, By Product, 2018 – 2023 (USD Million) 72

16.3.2. Japan Peritoneal Dialysis Market Revenue, By Product, 2024 – 2032 (USD Million) 72

16.4. End-user 73

16.4.1. Japan Peritoneal Dialysis Market Revenue, By End-user, 2018 – 2023 (USD Million) 73

16.4.2. Japan Peritoneal Dialysis Market Revenue, By End-user, 2024 – 2032 (USD Million) 73

CHAPTER NO. 17 : COMPANY PROFILES 74

17.1. Nipro Corporation 74

17.1.1. Company Overview 74

17.1.2. Product Portfolio 74

17.1.3. Swot Analysis 74

17.1.4. Business Strategy 75

17.1.5. Financial Overview 75

17.2. Baxter International Inc. 76

17.3. Fresenius Medical Care 76

17.4. Terumo Corporation 76

17.5. Asahi Kasei Medical Co., Ltd. 76

17.6. Huaren Pharmaceutical Co., Ltd. 76

17.7. JMS Co., Ltd. 76

17.8. Kawasumi Laboratories Inc. 76

17.9. Medtronic plc 76

17.10. Pacific Hospital Supply Co., Ltd. 76

List of Figures

FIG NO. 1. Japan Peritoneal Dialysis Market Revenue, 2018 – 2032 (USD Million) 22

FIG NO. 2. Porter’s Five Forces Analysis for Japan Peritoneal Dialysis Market 29

FIG NO. 3. Japan Peritoneal Dialysis Market Import Volume/Revenue, By Japan, 2018 – 2023 31

FIG NO. 4. Japan Peritoneal Dialysis Market Export Volume/Revenue, By Japan, 2018 – 2023 32

FIG NO. 5. Japan Peritoneal Dialysis Market Demand Volume/Revenue, By Japan, 2018 – 2023 33

FIG NO. 6. Japan Peritoneal Dialysis Market Supply Volume/Revenue, By Japan, 2018 – 2023 34

FIG NO. 7. Japan Peritoneal Dialysis Market Production Volume/Revenue, By Japan, 2018 – 2023 35

FIG NO. 8. Japan Peritoneal Dialysis Market Price, By Type, 2018 – 2023 36

FIG NO. 9. Raw Materials Price Trend Analysis, 2018 – 2023 37

FIG NO. 10. Manufacturing Cost Analysis 38

FIG NO. 11. Manufacturing Process 38

FIG NO. 12. Value Chain Analysis for Japan Peritoneal Dialysis Market 39

FIG NO. 13. Company Share Analysis, 2023 40

FIG NO. 14. Company Share Analysis, 2023 41

FIG NO. 15. Company Share Analysis, 2023 41

FIG NO. 16. Company Share Analysis, 2023 42

FIG NO. 17. Peritoneal Dialysis Market – Company Volume Market Share, 2023 43

FIG NO. 18. Peritoneal Dialysis Market – Company Revenue Market Share, 2023 44

FIG NO. 19. Peritoneal Dialysis Market Revenue Share, By Type, 2023 & 2032 50

FIG NO. 20. Market Attractiveness Analysis, By Type 51

FIG NO. 21. Incremental Revenue Growth Opportunity by Type, 2024 – 2032 51

FIG NO. 22. Peritoneal Dialysis Market Revenue, By Type, 2018, 2023, 2027 & 2032 52

FIG NO. 23. Japan Peritoneal Dialysis Market for Continuous Ambulatory Peritoneal Dialysis (CAPD), Revenue (USD Million) 2018 – 2032 53

FIG NO. 24. Japan Peritoneal Dialysis Market for Automated Peritoneal Dialysis (APD), Revenue (USD Million) 2018 – 2032 54

FIG NO. 25. Peritoneal Dialysis Market Revenue Share, By Product, 2023 & 2032 56

FIG NO. 26. Market Attractiveness Analysis, By Product 57

FIG NO. 27. Incremental Revenue Growth Opportunity by Product, 2024 – 2032 57

FIG NO. 28. Peritoneal Dialysis Market Revenue, By Product, 2018, 2023, 2027 & 2032 58

FIG NO. 29. Japan Peritoneal Dialysis Market for Peritoneal Dialysis Machines, Revenue (USD Million) 2018 – 2032 59

FIG NO. 30. Japan Peritoneal Dialysis Market for Peritoneal Dialysis Solutions, Revenue (USD Million) 2018 – 2032 60

FIG NO. 31. Japan Peritoneal Dialysis Market for Dialysis Catheters, Revenue (USD Million) 2018 – 2032 61

FIG NO. 32. Japan Peritoneal Dialysis Market for Others, Revenue (USD Million) 2018 – 2032 62

FIG NO. 33. Peritoneal Dialysis Market Revenue Share, By End-user, 2023 & 2032 64

FIG NO. 34. Market Attractiveness Analysis, By End-user 65

FIG NO. 35. Incremental Revenue Growth Opportunity by End-user, 2024 – 2032 65

FIG NO. 36. Peritoneal Dialysis Market Revenue, By End-user, 2018, 2023, 2027 & 2032 66

FIG NO. 37. Japan Peritoneal Dialysis Market for Hospitals, Revenue (USD Million) 2018 – 2032 67

FIG NO. 38. Japan Peritoneal Dialysis Market for Dialysis Centers, Revenue (USD Million) 2018 – 2032 68

FIG NO. 39. Japan Peritoneal Dialysis Market for Home Care Settings, Revenue (USD Million) 2018 – 2032 69

List of Tables

TABLE NO. 1. : Japan Peritoneal Dialysis Market: Snapshot 21

TABLE NO. 2. : Drivers for the Peritoneal Dialysis Market: Impact Analysis 25

TABLE NO. 3. : Restraints for the Peritoneal Dialysis Market: Impact Analysis 27

TABLE NO. 4. : Japan Peritoneal Dialysis Market Revenue, By Type, 2018 – 2023 36

TABLE NO. 5. : Key Raw Materials & Suppliers 37

TABLE NO. 6. : Japan Peritoneal Dialysis Market Revenue, By Type, 2018 – 2023 (USD Million) 70

TABLE NO. 7. : Japan Peritoneal Dialysis Market Revenue, By Type, 2024 – 2032 (USD Million) 70

TABLE NO. 8. : Japan Peritoneal Dialysis Market Revenue, By Product, 2018 – 2023 (USD Million) 71

TABLE NO. 9. : Japan Peritoneal Dialysis Market Revenue, By Product, 2024 – 2032 (USD Million) 71

TABLE NO. 10. : Japan Peritoneal Dialysis Market Revenue, By End-user, 2018 – 2023 (USD Million) 72

TABLE NO. 11. : Japan Peritoneal Dialysis Market Revenue, By End-user, 2024 – 2032 (USD Million) 72

Frequently Asked Questions

What is the current size of the Japan Peritoneal Dialysis market?

The Japan Peritoneal Dialysis market was valued at USD 578.32 million in 2023 and is projected to grow to USD 974.28 million by 2032, reflecting a compound annual growth rate (CAGR) of 6.26%.

What factors are driving the growth of the Japan Peritoneal Dialysis market?

The growth of the Japan Peritoneal Dialysis market is driven by the rising prevalence of chronic kidney disease (CKD), an aging population, and a growing preference for home-based dialysis solutions. Technological advancements in dialysis machines and solutions, along with government initiatives promoting healthcare accessibility, also contribute significantly to the market’s expansion.

What are the key segments within the Japan Peritoneal Dialysis market?

The market is segmented by type into Continuous Ambulatory Peritoneal Dialysis (CAPD) and Automated Peritoneal Dialysis (APD). It is also segmented by product into Peritoneal Dialysis Machines, Dialysis Solutions, Dialysis Catheters, and Others. The end-user segments include hospitals, dialysis centers, and home care settings, with regional segmentation into Kanto, Kansai, Chubu, Kyushu, and other regions.

What are some challenges faced by the Japan Peritoneal Dialysis market?

Key challenges include the high cost of peritoneal dialysis equipment and consumables, which can limit accessibility for some patients. Additionally, the risk of infections, such as peritonitis, and the need for strict adherence to treatment protocols present barriers to wider adoption. Ensuring proper training and support for home dialysis patients is another ongoing challenge.

Who are the major players in the Japan Peritoneal Dialysis market?

Prominent players in the market include Nipro Corporation, Baxter International Inc., Fresenius Medical Care, Terumo Corporation, Asahi Kasei Medical Co., Ltd., JMS Co., Ltd., Kawasumi Laboratories Inc., Medtronic plc, and Pacific Hospital Supply Co., Ltd. These companies lead the market with advanced dialysis solutions and technologies tailored to meet patient needs.

Purchase Options

Single User

$2699

Multi User

$3699

Custom Report

$5699

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –